Jabbarzadeh Kaboli P - Search Results

1

c-MET and the immunological landscape of cancer: novel therapeutic strategies for enhanced anti-tumor immunity.

Jabbarzadeh Kaboli P, Roozitalab G, Farghadani R, Eskandarian Z, Zerrouqi A. Jabbarzadeh Kaboli P, et al. Front Immunol. 2024 Nov 27;15:1498391. doi: 10.3389/fimmu.2024.1498391. eCollection 2024. Front Immunol. 2024. PMID: 39664377 Free PMC article. Review.

2

The evolution of BRAF-targeted therapies in melanoma: overcoming hurdles and unleashing novel strategies.

Imani S, Roozitalab G, Emadi M, Moradi A, Behzadi P, Jabbarzadeh Kaboli P. Imani S, et al. Among authors: jabbarzadeh kaboli p. Front Oncol. 2024 Nov 8;14:1504142. doi: 10.3389/fonc.2024.1504142. eCollection 2024. Front Oncol. 2024. PMID: 39582535 Free PMC article. Review.

3

Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer.

Jabbarzadeh Kaboli P, Chen HF, Babaeizad A, Roustai Geraylow K, Yamaguchi H, Hung MC. Jabbarzadeh Kaboli P, et al. Cancer Lett. 2024 Apr 28;588:216780. doi: 10.1016/j.canlet.2024.216780. Epub 2024 Mar 8. Cancer Lett. 2024. PMID: 38462033 Review.

4

Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinoma.

Roozitalab G, Abedi B, Imani S, Farghadani R, Jabbarzadeh Kaboli P. Roozitalab G, et al. Among authors: jabbarzadeh kaboli p. Cancer Metastasis Rev. 2024 Sep;43(3):889-918. doi: 10.1007/s10555-024-10174-x. Epub 2024 Feb 27. Cancer Metastasis Rev. 2024. PMID: 38409546 Review.

5

Unraveling the Potential of ALK-Targeted Therapies in Non-Small Cell Lung Cancer: Comprehensive Insights and Future Directions.

Parvaresh H, Roozitalab G, Golandam F, Behzadi P, Jabbarzadeh Kaboli P. Parvaresh H, et al. Among authors: jabbarzadeh kaboli p. Biomedicines. 2024 Jan 27;12(2):297. doi: 10.3390/biomedicines12020297. Biomedicines. 2024. PMID: 38397899 Free PMC article. Review.

6

Shedding light on triple-negative breast cancer with Trop2-targeted antibody-drug conjugates.

Jabbarzadeh Kaboli P, Shabani S, Sharma S, Partovi Nasr M, Yamaguchi H, Hung MC. Jabbarzadeh Kaboli P, et al. Am J Cancer Res. 2022 Apr 15;12(4):1671-1685. eCollection 2022. Am J Cancer Res. 2022. PMID: 35530278 Free PMC article. Review.

7

Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress.

Jabbarzadeh Kaboli P, Luo S, Chen Y, Jomhori M, Imani S, Xiang S, Wu Z, Li M, Shen J, Zhao Y, Wu X, Hin Cho C, Xiao Z. Jabbarzadeh Kaboli P, et al. Gene. 2022 Mar 30;816:146171. doi: 10.1016/j.gene.2021.146171. Epub 2022 Jan 10. Gene. 2022. PMID: 35026293

8

Analysis of Key Genes Regulating the Warburg Effect in Patients with Gastrointestinal Cancers and Selective Inhibition of This Metabolic Pathway in Liver Cancer Cells.

Zhang X, Guo J, Jabbarzadeh Kaboli P, Zhao Q, Xiang S, Shen J, Zhao Y, Du F, Wu X, Li M, Ji H, Yang X, Xiao Z, Wen Q. Zhang X, et al. Among authors: jabbarzadeh kaboli p. Onco Targets Ther. 2020 Jul 27;13:7295-7304. doi: 10.2147/OTT.S257944. eCollection 2020. Onco Targets Ther. 2020. PMID: 32801756 Free PMC article.

9

Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer - A comprehensive review from chemotherapy to immunotherapy.

Jabbarzadeh Kaboli P, Salimian F, Aghapour S, Xiang S, Zhao Q, Li M, Wu X, Du F, Zhao Y, Shen J, Cho CH, Xiao Z. Jabbarzadeh Kaboli P, et al. Pharmacol Res. 2020 Jun;156:104806. doi: 10.1016/j.phrs.2020.104806. Epub 2020 Apr 12. Pharmacol Res. 2020. PMID: 32294525 Review.

10

Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy.

Wu Y, Li J, Jabbarzadeh Kaboli P, Shen J, Wu X, Zhao Y, Ji H, Du F, Zhou Y, Wang Y, Zhang H, Yin J, Wen Q, Cho CH, Li M, Xiao Z. Wu Y, et al. Among authors: jabbarzadeh kaboli p. Pharmacol Res. 2020 May;155:104691. doi: 10.1016/j.phrs.2020.104691. Epub 2020 Feb 15. Pharmacol Res. 2020. PMID: 32070721 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters